Management of Children With or Exposed to HIV

  • Authors: James A. McAuley, MD, MPH; Mariam Aziz, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 9/5/21 (What's New)

References

Aboulker JP, Babiker A, Chaix ML, et al. Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome. AIDS. 2004;18:237-245.[Aboulker 2004]

Bekker A, Capparelli E, Violari A, et al. Abacavir dosing in neonates from birth: a pharmacokinetic analysis. Program and abstracts of the 2021 Conference on Retroviruses and Opportunistic Infections; March 6-10, 2021; Virtual. Abstract 605.[Bekker 2021]

Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA. 2005;293:2221-2231.[Berk 2005]

Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17....

Action required